A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. The results were presented at the 2025 American Society of Clinical ...
Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy alone1 Nearly one in three patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results